Clinical Trials

Prostatic Neoplasms

NCT01314118 2026-02-24

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

131 enrolled 12 charts

Prostatic Neoplasms

NCT03565835 2026-01-26

Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer

31 enrolled 11 charts

Prostatic Neoplasms

NCT01995058 2026-01-08

Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC

54 enrolled 11 charts

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT03431350 2025-12-23

QUEST

136 enrolled 29 charts

Prostatic Neoplasms, Castration-Resistant

NCT03007732 2025-12-05

Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT

23 enrolled 14 charts

Prostatic Neoplasms

NCT03098836 2025-09-12

PANTHER

93 enrolled 17 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT03298087 2025-08-01

Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer

28 enrolled 10 charts

Newly Diagnosed Oligometastatic Prostate Cancer

NCT02903368 2025-06-13

Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy

118 enrolled 23 charts

Prostatic Neoplasms

NCT02025010 2025-04-15

Study of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate Cancer

60 enrolled 17 charts

Castration-resistant Prostate Cancer

NCT01309672 2025-02-26

S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy

41 enrolled 18 charts

Prostatic Neoplasms

NCT01254864 2025-01-27

Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies

190 enrolled 9 charts

Prostatic Neoplasms

NCT01650194 2024-12-10

A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients

60 enrolled 24 charts

Tumor-Agnostic

Neoplasms

NCT02218606 2024-12-10

Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer

81 enrolled 11 charts

Prostatic Neoplasms

NCT02903160 2024-02-07

Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)

40 enrolled 18 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT03649841 2023-10-26

Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer

10 enrolled 7 charts

Prostatic Neoplasms

NCT03043807 2023-02-16

A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy

26 enrolled 8 charts

Prostatic Neoplasms

NCT01717053 2022-10-10

Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer

37 enrolled 15 charts

Prostatic Neoplasms

NCT03279250 2022-08-10

Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer

86 enrolled 9 charts

Prostatic Neoplasms

NCT01681433 2022-07-11

OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone

72 enrolled 14 charts

Prostatic Neoplasms

NCT02268175 2022-04-19

Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate

75 enrolled 12 charts

Prostatic Neoplasms

NCT02849990 2022-01-13

A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy

22 enrolled 11 charts

Prostatic Neoplasms

NCT02737332 2021-11-22

STAAR

53 enrolled 19 charts

Prostatic Neoplasms

NCT01751451 2021-11-19

3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy

124 enrolled 11 charts

Prostatic Neoplasms

NCT02962284 2021-11-19

One-year, Open Extension to Evaluate the Treatment of Patients With Castration-Resistant Prostate Cancer With YONSA™

20 enrolled 12 charts

Prostatic Neoplasms

NCT01503229 2021-05-14

Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

32 enrolled 6 charts

Prostatic Neoplasms

NCT03418324 2020-12-30

Study of TRC105 With Abiraterone and With Enzalutamide in Prostate Cancer Patients Progressing on Therapy

11 enrolled 17 charts

Prostatic Neoplasms

NCT01940276 2020-12-09

Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer

100 enrolled 12 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT01576172 2020-11-12

Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

159 enrolled 12 charts

Prostatic Neoplasms

NCT01637402 2020-08-17

A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer

41 enrolled 14 charts

Tumor-Agnostic

Neoplasms

NCT03827473 2020-06-25

ACADEMIC

1 enrolled 6 charts

Prostatic Neoplasms

NCT01946165 2019-12-06

Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide

69 enrolled 9 charts

Prostatic Neoplasms

NCT02034552 2019-07-23

A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC)

68 enrolled 17 charts

Prostatic Neoplasms

NCT01543776 2019-07-05

Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer

72 enrolled 13 charts

Prostatic Neoplasms

NCT01867710 2019-07-05

Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to Chemotherapy

164 enrolled 22 charts

Hyperaldosteronism, Prostatic Neoplasms

NCT02379390 2019-06-21

PRIMCAB

8 enrolled 8 charts

Prostate Cancer Metastatic

NCT01381874 2019-04-11

A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

297 enrolled 19 charts

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01487863 2019-03-19

Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer

69 enrolled 14 charts

Prostatic Neoplasms

NCT01994590 2019-03-19

Dovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

4 enrolled 8 charts

Prostatic Neoplasms

NCT01685983 2019-03-15

A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer

82 enrolled 13 charts

Prostatic Neoplasms

NCT01553188 2019-03-05

AMG 386 and Abiraterone for Advanced Prostate Cancer

36 enrolled 18 charts

Prostatic Neoplasms

NCT01845792 2018-06-04

Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate Cancer

7 enrolled 10 charts

Prostatic Neoplasms

NCT01393730 2018-03-15

Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer

40 enrolled 12 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT02097303 2018-02-01

eRADicAte

36 enrolled 13 charts

Prostatic Neoplasms

NCT01023061 2017-06-06

RAD1

24 enrolled 5 charts

Prostatic Neoplasms

NCT01735396 2017-05-12

Abiraterone Acetate Trial in African American Prostate Cancer Patients

11 enrolled 5 charts

Prostatic Neoplasms

NCT00544440 2014-07-17

An Observational Study of Continuous Oral Dosing of Abiraterone Acetate in Castration-Resistant Prostate Cancer Patients Evaluating Androgens and Steroid Metabolites in Bone Marrow Plasma

57 enrolled 6 charts

Prostatic Neoplasms

NCT01088529 2014-05-15

Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer

66 enrolled 12 charts

Prostatic Neoplasms

NCT00474383 2014-05-12

An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy

47 enrolled 13 charts

Prostatic Neoplasms

NCT00485303 2013-07-02

An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy

58 enrolled 14 charts